SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Wolfgang Amadeus Mozart — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientWolfgang Amadeus Mozart
Date of birth1756-01-27
IdentifiersMRN HR-EN009-SYN-TD; SSN (made up) 000-09-3517
Document date1784-09-15
AuthorTheodora Kranzler-Obi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for swelling of the face and legs and dark urine after a sore throat: urgent kidney and streptococcal tests, treatment of fluid overload and the infection, and an urgent nephrology referral [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

10 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
late 1762Scarlet fever at about six, with two weeks in bedD (CLM-0002)
autumn 1765A violent fever at nine that left him very weak for several weeksD (CLM-0003)
1767Smallpox at eleven, severe, with nine days of blindness; recovered with no lasting eye problem recordedD (CLM-0004)
spring 1783An acute illness described as cholera, during an epidemic, at 27D (CLM-0005)
before 1784Frequent sore throats (tonsillitis) through life, a retrospective interpretationR (CLM-0015)

Family History

RelativeConditionAge at deathEvidence
motherDied while traveling abroad after an illness of some weeks; cause not recorded in the cited sourceD (CLM-0008)
siblingFive of the seven children of his parents died young; causes not recorded in the cited sourceD (CLM-0001)

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Penicillin V potassium 500 mg tablet, one tablet by mouth twice a day for ten daystwice a day for 10 daysOral route1784-09-15 to 1784-09-25completedS
Furosemide 40 mg tablet, one tablet by mouth each morning while swollenonce each morningOral route1784-09-15 to 1784-09-29stoppedS

Review of Systems

Positive for the concerns in the history of present illness. Alert, quick, and talkative; worried about his kidneys and about losing work; PHQ-2 score 1. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in all activities; has cancelled three days of lessons; too tired and swollen to sit at the keyboard for long. [S]

Physical Exam

Vital signs recorded on 1784-09-15; see the Vital Signs section. Mental status: Alert, quick, and talkative; worried about his kidneys and about losing work; PHQ-2 score 1. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Vital Signs

DateMeasureValueUnitProvenance
1784-09-15Body height163cmS
1784-09-15Body weight64.2kgS
1784-09-15Body mass index (BMI) [Ratio]24.2kg/m2S
1784-09-15Systolic blood pressure162mm[Hg]S
1784-09-15Diastolic blood pressure100mm[Hg]S
1784-09-15Heart rate88/minS
1784-09-15Respiratory rate18/minS
1784-09-15Body temperature37.6CelS
1784-09-15Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1784-09-15Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
1784-09-15Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
1784-09-15Urea nitrogen [Mass/volume] in Serum or Plasma31mg/dL6-24 mg/dLHighS
1784-09-15Creatinine [Mass/volume] in Serum or Plasma1.62mg/dL0.74-1.35 mg/dLHighS
1784-09-15Albumin [Mass/volume] in Serum or Plasma3.6g/dL3.5-5 g/dLNormalS
1784-09-15Hemoglobin [Mass/volume] in Blood13.4g/dL13.2-17.1 g/dLNormalS
1784-09-15Leukocytes [#/volume] in Blood by Automated count8.910*3/uL3.8-10.8 10*3/uLNormalS
1784-09-15Platelets [#/volume] in Blood by Automated count26510*3/uL140-400 10*3/uLNormalS
1784-09-15C reactive protein [Mass/volume] in Serum or Plasma18mg/L<=8 mg/LHighS
1784-09-15Erythrocyte [Sedimentation Rate] in Blood by Westergren method38mm/h<=15 mm/hHighS
1784-09-15Complement C3 [Mass/volume] in Serum or Plasma42mg/dL90-180 mg/dLLowS
1784-09-15Complement C4 [Mass/volume] in Serum or Plasma24mg/dL10-40 mg/dLNormalS
1784-09-15Streptolysin O Ab [Units/volume] in Serum or Plasma620[IU]/mL<=200 [IU]/mLHighS
1784-09-15Streptococcal DNAse B [Units/volume] in Serum980[IU]/mL<=240 [IU]/mLHighS
1784-09-15Erythrocytes [#/area] in Urine sediment by Microscopy high power field60/[HPF]<=2 /[HPF]HighS
1784-09-15Protein/Creatinine [Mass Ratio] in Urine1400mg/g<=150 mg/gHighS
1784-09-15Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1779)/1.73 sq M59mL/min/{1.73_m2}60 or moreLowS
1784-09-15Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1784-09-15Total score [AUDIT-C]2{score}S

Problems

ProblemClinical statusVerificationCodeProvenance
Swelling of the face and legs with cola-colored urine, less urine, raised blood pressure, and reduced kidney function (acute nephritic picture), two to three weeks after a febrile sore throat and followed by aching knees and ankles, crampy abdominal pain, and vomiting; cause not yet confirmed at intake; urgent nephrology consultation requestedactiveconfirmed R60.1S — Synthetic presenting problem anchored to his documented febrile illness of 1784; superseded by the diagnosis at the nephrology consultation.
Group A streptococcal pharyngitis, rapid antigen test positive at intake with a mildly red throat two to three weeks after the sore throat began; penicillin V startedactiveconfirmed J02.0S — Synthetic modern infection that triggers the episode; his recurrent sore throats are a retrospective interpretation (CLM-0015).

Assessment

Plan of Treatment